Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Vivos Therapeutics, Inc. (VVOS) had Stock-Based Compensation of $0.66M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$17.44M |
|
$-21.17M |
|
$6.90M |
|
$10.54M |
|
$37.34M |
|
$-19.89M |
|
$-1.34M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-19.89M |
|
$-18.59M |
|
10.27M |
|
10.27M |
|
$-2.07 |
|
$-2.07 |
|
| Balance Sheet Financials | |
$4.38M |
|
$3.76M |
|
$20.77M |
|
$25.15M |
|
$18.08M |
|
$0.47M |
|
$8.63M |
|
$26.70M |
|
$-1.43M |
|
$-14.17M |
|
$-1.55M |
|
9.29M |
|
| Cash Flow Statement Financials | |
$-15.26M |
|
$-7.53M |
|
$18.56M |
|
$6.26M |
|
$2.03M |
|
$-4.23M |
|
|
Stock-Based Compensation |
$0.66M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-0.43 |
|
-5.69 |
|
60.44% |
|
-114.05% |
|
-114.05% |
|
-106.55% |
|
-121.71% |
|
-121.37% |
|
$-17.60M |
|
-- |
|
-- |
|
-- |
|
0.69 |
|
-- |
|
11.03 |
|
33.08 |
|
1484.61% |
|
149.86% |
|
-84.41% |
|
1963.92% |
|
$-0.17 |
|
$-1.71 |
|
$-1.49 |
|